{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:33:43Z","timestamp":1792791223065,"version":"4.5.0"},"reference-count":13,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T00:00:00Z","timestamp":1738108800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000864","name":"Michael J Fox Foundation for Parkinson's Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018231","name":"Aligning Science Across Parkinson's","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018231","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.nbd.2025.106820","type":"journal-article","created":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T08:11:27Z","timestamp":1738224687000},"page":"106820","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Current safety recommendations for handling mouse and human \u03b1synuclein pre-formed fibrils"],"prefix":"10.1016","volume":"206","author":[{"given":"Lauren","family":"Fielding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marissa A.","family":"Menard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Roth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Iuliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Dehay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Aguilar-Calvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura A.","family":"Volpicelli-Daley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2025.106820_bb0005","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02095-16","article-title":"Robust central nervous system pathology in transgenic mice following peripheral injection of alpha-synuclein fibrils","volume":"91","author":"Ayers","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.nbd.2025.106820_bb0010","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3233\/JPD-150691","article-title":"An efficient procedure for removal and inactivation of alpha-Synuclein assemblies from laboratory materials","volume":"6","author":"Bousset","year":"2016","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.nbd.2025.106820_bb0015","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1093\/brain\/awz329","article-title":"Intrastriatal injection of alpha-synuclein fibrils induces Parkinson-like pathology in macaques","volume":"142","author":"Dehay","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2025.106820_bb0020","doi-asserted-by":"crossref","first-page":"10392","DOI":"10.1074\/jbc.RA119.007743","article-title":"Defining alpha-synuclein species responsible for Parkinson\u2019s disease phenotypes in mice","volume":"294","author":"Froula","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2025.106820_bb0025","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/mds.27646","article-title":"Comparative study of cerebrospinal fluid alpha-synuclein seeding aggregation assays for diagnosis of Parkinson\u2019s disease","volume":"34","author":"Kang","year":"2019","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2025.106820_bb0030","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/s41531-021-00242-2","article-title":"Diagnostic value of skin RT-QuIC in Parkinson's disease: a two-laboratory study","volume":"7","author":"Kuzkina","year":"2021","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.nbd.2025.106820_bb0035","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1126\/science.1227157","article-title":"Pathological alpha-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice","volume":"338","author":"Luk","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.nbd.2025.106820_bb0040","doi-asserted-by":"crossref","first-page":"3373","DOI":"10.1016\/j.celrep.2016.08.053","article-title":"Molecular and biological compatibility with host alpha-Synuclein influences fibril pathogenicity","volume":"16","author":"Luk","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.nbd.2025.106820_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2023.105440","article-title":"Single-dose intranasal administration of alpha-syn PFFs induce lewy neurite-like pathology in olfactory bulbs","volume":"112","author":"Sawamura","year":"2023","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.nbd.2025.106820_bb0050","doi-asserted-by":"crossref","first-page":"eadq3539","DOI":"10.1126\/sciadv.adq3539","article-title":"Mouse alpha-synuclein fibrils are structurally and functionally distinct from human fibrils associated with Lewy body diseases","volume":"10","author":"Sokratian","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.nbd.2025.106820_bb0055","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41531-023-00579-w","article-title":"Cortical Lewy body injections induce long-distance pathogenic alterations in the non-human primate brain","volume":"9","author":"Teil","year":"2023","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.nbd.2025.106820_bb0060","doi-asserted-by":"crossref","first-page":"6892","DOI":"10.1038\/s41467-023-42705-5","article-title":"Alpha-Synuclein aggregates amplified from patient-derived Lewy bodies recapitulate Lewy body diseases in mice","volume":"14","author":"Uemura","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.nbd.2025.106820_bb0065","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.neuron.2011.08.033","article-title":"Exogenous alpha-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death","volume":"72","author":"Volpicelli-Daley","year":"2011","journal-title":"Neuron"}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996125000361?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996125000361?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T07:43:16Z","timestamp":1740469396000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996125000361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":13,"alternative-id":["S0969996125000361"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2025.106820","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current safety recommendations for handling mouse and human \u03b1synuclein pre-formed fibrils","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2025.106820","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"106820"}}